The National Institutes of Health (NIH) has recently canceled several scientific research grants at Emory University and the University of Pittsburgh. These projects were primarily focused on Alzheimer’s disease and broader brain health initiatives. The cancellations have drawn sharp criticism from researchers who view the decision as a form of political interference in scientific inquiry.

According to reports, the administration’s decision appears to target specific research projects that incorporate the study of racism as a factor in health disparities. Ann Cohen, an associate professor of psychiatry at the University of Pittsburgh, publicly criticized the move, stating that political intervention is detrimental to the scientific process. The administration has not yet issued a detailed public statement explaining the specific criteria used to select these particular grants for termination, though the action is being framed by observers as part of a broader effort to remove diversity, equity, and inclusion (DEI) initiatives from federal funding portfolios.

There is a clear divide in how the motivation behind these cancellations is interpreted. While academic researchers and critics characterize the move as an ideologically driven attack on specific areas of social science, supporters of the administration’s broader policy agenda often frame such funding reviews as necessary oversight to ensure taxpayer money is not being used for research they deem non-essential or politically biased. Currently, the scientific community remains concerned that these cancellations could set a precedent for future funding decisions, potentially narrowing the scope of what is considered acceptable research under the current administration.